2008•Chinese Medical of Factory and MineRequires access

Prophylactic effect of pioglitazone to alcoholic hepatic diseases in rats

Zhang Huai-shen

Open publisher page 0 citations

Abstract

Objective To study the prophylactic effect of pioglitazone to alcoholic hepatic diseases in rats.Methods A total of 100 SD rats were randomly divided into blank control group(20),model group(40) and pioglitazone group(40). Blank control group were given normal diet;model group were given gradient(5%~22%)and 54% alcohol;pioglitazone group were given pioglitazone(5 mg·kg-1·d-1) every day when given gradient(5%~22%)and 54% alcohol.The levels of ALT and AST in serum of rats were detected on 5th and 10th week respectively and then half of rats in each group were killed on 5th and 10th wecks.Slices of liver were stained by HE and the changes of pathology were observed.Results In model group,the levels of ALT and AST were (63.0±9.9),(84.0±10.6)U/L and (82.0±12.5),(163.0±21.4)U/L respectively on 5th and 10th week,and there was significant increase compared with blank control group(P0.05).The fatty degenerations were found after 5 weeks in 45%(9/20)of the rats;the fatty degenerations were found in 90%(18/20) of the rats,and the changes of alcoholic hepatitis were found in 50%(10/20) of the rats after 10 weeks in the model group.In pioglitazone group,the levels of ATL and AST were (48.0±8.6),(64.0±7.9)U/L and (62.0±13.6),(83.0±16.1)U/L respectively on 5th and 10th week,and there was significant dicrease compared with model group (P0.05) and significant increase compared with control group(P0.05).30%(6/20) of the rats were found fatty degeneration after 5 weeks; 70%(14/20) were found fatty degeneration and 30%(6/20) were found alcoholic hepatitis after 10 weeks.Conclusions Pioglitazone has a prophylactic effect to alcoholic hepatic diseases in certain degree.

About this research paper

What this paper is about

Objective To study the prophylactic effect of pioglitazone to alcoholic hepatic diseases in rats.Methods A total of 100 SD rats were randomly divided into blank control group(20),model group(40) and pioglitazone group(40). Blank control group were given normal diet;model group were given gradient(5%~22%)and 54% alcohol;pioglitazone group were given pioglitazone(5 mg·kg-1·d-1) every day when given gradient(5%~22%)and 54% alcohol.The levels of ALT and AST in serum of rats were detected on 5th and 10th week respectively and then half of rats in each group were killed on 5th and 10th wecks.Slices of liver were stained by HE and the changes of pathology were observed.Results In model group,the levels of ALT and AST were (63.0±9.9),(84.0±10.6)U/L and (82.0±12.5),(163.0±21.4)U/L respectively on 5th and 10th week,and there was significant increase compared with blank control group(P0.05).The fatty degenerations were found after 5 weeks in 45%(9/20)of the rats;the fatty degenerations were found in 90%(18/20) of the rats,and the changes of alcoholic hepatitis were found in 50%(10/20) of the rats after 10 weeks in the model group.In pioglitazone group,the levels of ATL and AST were (48.0±8.6),(64.0±7.9)U/L and (62.0±13.6),(83.0±16.1)U/L respectively on 5th and 10th week,and there was significant dicrease compared with model group (P0.05) and significant increase compared with control group(P0.05).30%(6/20) of the rats were found fatty degeneration after 5 weeks; 70%(14/20) were found fatty degeneration and 30%(6/20) were found alcoholic hepatitis after 10 weeks.Conclusions Pioglitazone has a prophylactic effect to alcoholic hepatic diseases in certain degree.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the prophylactic effect of pioglitazone to alcoholic hepatic diseases in rats.Methods A total of 100 SD rats were randomly divided into blank control group(20),model group(40) and pioglitazone group(40). Blank control group were given normal diet;model group were given gradient(5%~22%)and 54% alcohol;pioglitazone group were given pioglitazone(5 mg·kg-1·d-1) every day when given gradient(5%~22%)and 54% alcohol.The levels of ALT and AST in serum of rats were detected on 5th and 10th week respectively and then half of rats in each group were killed on 5th and 10th wecks.Slices of liver were stained by HE and the changes of pathology were observed.Results In model group,the levels of ALT and AST were (63.0±9.9),(84.0±10.6)U/L and (82.0±12.5),(163.0±21.4)U/L respectively on 5th and 10th week,and there was significant increase compared with blank control group(P0.05).The fatty degenerations were found after 5 weeks in 45%(9/20)of the rats;the fatty degenerations were found in 90%(18/20) of the rats,and the changes of alcoholic hepatitis were found in 50%(10/20) of the rats after 10 weeks in the model group.In pioglitazone group,the levels of ATL and AST were (48.0±8.6),(64.0±7.9)U/L and (62.0±13.6),(83.0±16.1)U/L respectively on 5th and 10th week,and there was significant dicrease compared with model group (P0.05) and significant increase compared with control group(P0.05).30%(6/20) of the rats were found fatty degeneration after 5 weeks; 70%(14/20) were found fatty degeneration and 30%(6/20) were found alcoholic hepatitis after 10 weeks.Conclusions Pioglitazone has a prophylactic effect to alcoholic hepatic diseases in certain degree.

Key concepts: Pioglitazone, Medicine, Fatty liver, Internal medicine, Gastroenterology, Alcohol, Endocrinology, Alcoholic fatty liver

Related papers

Back to paper searchBrowse research topicsOriginal source
Prophylactic effect of pioglitazone to alcoholic hepatic diseases in rats — Research Paper | ScholarLens